Critical biomarkers of epithelial-mesenchymal transition in the head and neck cancers

J Cancer Res Ther. 2014 Jul-Sep;10(3):512-8. doi: 10.4103/0973-1482.137926.

Abstract

Epithelial-mesenchymal transition (EMT), a key developmental program has been shown to occur in wound healing, organ fibrosis and in the initiation of metastasis for cancer progression. EMT is a process that describes the development of motile, mesenchymal-like cells from non-motile parent epithelial cells. Plasticity of the cells enable significant changes in cell phenotypes and this process is governed by the interplay among different functional classes of regulatory molecules. The process typically involves the control of specific gene expression programs with distinct functional impacts on the behavior of cells. An important feature of cellular plasticity, EMT has in the recent times attracted broad interest in the field of cancer research, tumor invasion and metastases. A complete understanding of the molecular events of EMT and a search for novel molecular regulators is required for prospective targets for therapeutic interventions. This review summarizes the critical biomarkers of EMT in the head and neck cancers.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Cadherins / genetics
  • Cadherins / metabolism
  • Epigenesis, Genetic
  • Epithelial-Mesenchymal Transition* / genetics
  • Gene Expression Regulation, Neoplastic
  • Head and Neck Neoplasms / etiology
  • Head and Neck Neoplasms / metabolism*
  • Head and Neck Neoplasms / pathology*
  • Humans
  • Integrins / genetics
  • Integrins / metabolism
  • Neoplastic Stem Cells / metabolism
  • Peptide Hydrolases / genetics
  • Peptide Hydrolases / metabolism
  • Phenotype
  • Signal Transduction
  • Transcription Factors
  • Tumor Microenvironment

Substances

  • Biomarkers
  • Cadherins
  • Integrins
  • Transcription Factors
  • Peptide Hydrolases